Drug intelligence / Profile preview

albuterol sulfate (Teva Pharmaceutical Industries Ltd.)

Development stage
Unknown
Lead developer
Teva Pharmaceutical Industries
Modality
Small Molecules
Administration
Inhalation
01

Overview

Albuterol sulfate is a short-acting beta-2 adrenergic agonist (SABA) developed by Teva Branded Pharmaceutical Products R&D, Inc. for the treatment and prevention of bronchospasm in patients with asthma or exercise-induced bronchospasm. It acts by binding to beta-2 adrenergic receptors in bronchial smooth muscle, leading to activation of adenyl cyclase and an increase in cyclic AMP, which results in muscle relaxation and bronchodilation. Teva's specific formulation is delivered via a multidose dry powder inhaler (eMDPI) known as the Digihaler, which incorporates an electronic module and sensors to record inhaler events and measure inspiratory flow, providing data to patients and healthcare providers via a mobile application. This technology is intended to help monitor adherence and inhaler technique in clinical and real-world settings.

Brand names
ProAir Digihaler
Other names
salbutamol sulfatealbuterol sulfate eMDPI
02

Targets

ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on albuterol sulfate (Teva Pharmaceutical Industries Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albuterol sulfate (Teva Pharmaceutical Industries Ltd.).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call